Prentiss Smith & CO Inc Bristol Myers Squibb CO Transaction History

Prentiss Smith & CO Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$72.62 - $79.98 $502,239 - $553,141	-6,916 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$61.48 - $73.72 $27,358 - $32,805	-445 Reduced 6.05%	6,916 $505,000
Q4 2021 Jan 28, 2022	SELL	$53.63 - $62.52 $7,508 - $8,752	-140 Reduced 1.87%	7,361 $459,000
Q3 2021 Oct 19, 2021	SELL	$59.17 - $69.31 $22,484 - $26,337	-380 Reduced 4.82%	7,501 $444,000
Q2 2021 Jul 15, 2021	SELL	$61.91 - $67.42 $90,388 - $98,433	-1,460 Reduced 15.63%	7,881 $527,000
Q1 2021 Jun 21, 2021	SELL	$59.34 - $66.74 $23,142 - $26,028	-390 Reduced 4.01%	9,341 $590,000
Q4 2020 Feb 03, 2021	BUY	$57.74 - $65.43 $32,738 - $37,098	567 Added 6.19%	9,731 $604,000
Q3 2020 Nov 02, 2020	BUY	$57.43 - $63.64 $32,160 - $35,638	560 Added 6.51%	9,164 $552,000
Q1 2020 Apr 29, 2020	SELL	$46.4 - $67.43 $1,392 - $2,022	-30 Reduced 0.35%	8,604 $480,000
Q4 2019 Jan 21, 2020	BUY	$49.21 - $64.19 $424,879 - $554,216	8,634 New	8,634 $554,000
Q4 2018 Jan 15, 2019	SELL	$48.76 - $63.23 $113,757 - $147,515	-2,333 Closed	0 $0
Q3 2017 May 03, 2018	BUY	$55.23 - $63.74 $128,851 - $148,705	2,333	2,333 $149,000

2,402

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $110B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Prentiss Smith & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Prentiss Smith & CO Inc with notifications on news.